Mercury Laboratories Ltd share price logo

Mercury Laboratories Ltd Share Price

BSE: 538964

Small Cap

Healthcare Sector

₹864.20

-39.80

(-4.40%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Mercury Laboratories Ltd Stock Performance

as on October 31, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹863.55
    ₹903.45
    downward going graph

    0.08%

    Downside

    4.54%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹736
    ₹1,016
    downward going graph

    14.83%

    Downside

    17.57%

    Upside

    downward going graph

Mercury Laboratories Ltd share price movements today

Previous Close
₹904.00
Open
₹903.45
Volume
135.00
Upper Circuit
₹949.20
Lower Circuit
₹858.80
Day's Low - High
₹863.55 - ₹903.45
52 Week Low - High
₹736 - ₹1,016

Mercury Laboratories Ltd Historical Returns

1 Month Return
+ 1.67 %
3 Month Return
-3.28 %
1 Year Return
-8.04 %
3 Year Return
+ 49.57 %
5 Year Return
+ 115.24 %

Mercury Laboratories Ltd Fundamentals

as on October 31, 2025 at 4:01 pm IST

Market Cap

₹103.70 Cr

Return on Equity (ROE)

6.01

PE Ratio (TTM)

0

Return on capital employed (ROCE)

8.98

Beta (LTM)

0.47

P/B Ratio

1.83

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

185.29

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Mercury Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mercury Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mercury Laboratories Ltd image
Mercury Laboratories Ltd
NA103.7023.05%0.00375
Quest Laboratories Ltd image
Quest Laboratories Ltd
NA146.09-7.9%0.0013103
Wanbury Ltd image
Wanbury Ltd
NA916.74134.62%0.8830599
Gujarat Themis Biosyn Ltd image
Gujarat Themis Biosyn Ltd
NA5,067.97264.2%0.0048150
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA14.6765.11%0.00-1NA
See all

Mercury Laboratories Ltd Stock’s Investor Sentiment and Interest

Search interest for Mercury Laboratories Ltd Stock has increased by 126% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:126% versus previous 30 day period

Mercury Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
16.23
19.43
18.32
22.76
17.11
17.37
16.68
18.19
19.57
20.66
18.14
Other Income
0.58
0.43
0.15
0.36
0.18
0.41
0.15
0.21
0.53
0.18
0.18
Total Income
16.81
19.86
18.47
23.11
17.29
17.78
16.83
18.4
20.1
20.84
18.32
Expenses
15.65
18.39
16.66
20.27
14.89
14.72
15.07
16.88
17.6
18.54
15.78
Operating Profit
0.58
1.04
1.66
2.49
2.22
2.65
1.61
1.31
1.97
2.12
2.36
Operating Profit Margin %
3.57%
5.35%
9.06%
10.94%
12.97%
15.26%
9.65%
7.2%
10.07%
10.26%
13.01%
Profit Before Interest, Tax and Depreciation
1.16
1.47
1.81
2.84
2.41
3.06
1.76
1.52
2.51
2.31
2.54
Interest
0.08
0.1
0.08
0.11
0.1
0.1
0.14
0.15
0.13
0.13
0.15
Depreciation
0.63
0.62
0.68
0.71
0.72
0.72
0.7
0.71
0.74
0.73
0.84
Profit Before Tax
0.45
0.75
1.05
2.02
1.59
2.24
0.92
0.66
1.64
1.45
1.55
Tax Paid
-0.16
0.38
0.06
0.52
0.35
0.34
0.58
0.15
0.45
0.34
0.58
Profit After Tax
0.61
0.37
1
1.51
1.24
1.91
0.34
0.5
1.19
1.11
0.97
Total Net profit including share of profit / Loss from associate company
0.61
0.37
1
1.51
1.24
1.91
0.34
0.5
1.19
1.11
0.97
EPS
5.05
3.05
8.33
12.56
10.3
15.92
2.85
4.17
9.94
9.25
8.06
Actual EPS
5.05
3.05
8.33
12.56
10.3
15.92
2.85
4.17
9.94
9.25
8.06
Adjusted EPS
5.05
3.05
8.33
12.56
10.3
15.92
2.85
4.17
9.94
9.25
8.06
Diluted EPS
5.05
3.05
8.33
12.56
10.3
15.92
2.85
4.17
9.94
9.25
8.06

Mercury Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
48.03
51.87
55.52
57.27
68.6
57.92
75.33
75.56
75.1
Other Income
0.35
0.42
1.04
0.85
0.88
0.94
1.72
1.09
1.07
Total Income
48.38
52.29
56.56
58.12
69.48
58.87
77.05
76.65
76.17
Expenses
41.31
47.45
49.8
51.1
59.01
50.93
66.76
66.53
68.08
Operating Profit
6.72
4.42
5.72
6.17
9.59
6.99
8.57
9.03
7.02
Operating Profit Margin %
13.99%
8.52%
10.3%
10.77%
13.98%
12.07%
11.38%
11.95%
9.35%
Profit Before Interest, Tax and Depreciation
7.07
4.84
6.77
7.02
10.47
7.93
10.29
10.12
8.09
Interest
0.89
0.91
1.09
0.82
0.64
0.45
0.36
0.38
0.55
Depreciation
1.29
1.47
1.63
1.87
1.92
2.45
2.48
2.82
2.88
Profit Before Tax
4.89
2.46
4.05
4.33
7.91
5.03
7.45
6.92
4.66
Tax Paid
2.19
0.44
1.21
1.1
2.57
1.47
1.86
1.27
1.52
Profit After Tax
2.7
2.01
2.84
3.23
5.34
3.56
5.58
5.65
3.14
Total Net profit including share of profit / Loss from associate company
2.7
2.01
2.84
3.23
5.34
3.56
5.58
5.65
3.14
EPS
22.52
16.78
23.64
26.9
44.48
29.68
46.49
47.12
26.21
Actual EPS
22.52
16.78
23.64
26.9
44.48
29.68
46.49
47.12
26.21
Adjusted EPS
22.52
16.78
23.64
26.9
44.48
29.68
46.49
47.12
26.21
Diluted EPS
22.52
16.78
23.64
26.9
44.48
29.68
46.49
47.12
26.21

Mercury Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.1
1.92
4.97
5.22
5.49
8.21
5.19
2.45
8.23
4
Cash Flow from Investing Activities
-0.28
-1.5
-3.68
-4.99
-1.14
-4.62
-1.89
-1.06
-6.27
-9.04
Cash Flow from Financing Activities
0.47
-0.26
1.07
-2.55
-3.34
-1.24
-1.24
-1
-1.04
-0.99
Net Cash Flow
0.09
0.17
2.36
-2.31
1.02
2.36
2.07
0.38
0.91
-6.03

Mercury Laboratories Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
73.66%
Public
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
26.34%
Total Outstanding Shares
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
12,00,000
Total Shareholders
1,187
1,146
1,119
1,149
1,161
1,214
1,259
1,345
1,411
1,397
1,384
1,365

Mercury Laboratories Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Mercury Laboratories Ltd.

  • Mercury Laboratories Ltd Earnings Results

    Mercury Laboratories Ltd’s net profit jumped 185.29% since last year same period to ₹0.97Cr in the Q1 2025-2026. On a quarterly growth basis, Mercury Laboratories Ltd has generated -12.61% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Mercury Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Mercury Laboratories Ltd has declared dividend of ₹3.50 per share on 14 May 2025 - translating a dividend yield of 0.81%.

    Read More about Dividends

Insights on Mercury Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Mercury Labs stock has moved up by 2.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 14.1% return, outperforming this stock by 14.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 26.34% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 73.66% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 111.1% return, outperforming this stock by 63.1%

About Mercury Laboratories Ltd

Mercury Laboratories Limited is a long-standing and profitable public limited company based in Maharashtra. Founded as a partnership in 1962, the company was incorporated as a Private Limited in 1982 before becoming a Limited Company in 1992. Since then, the company has been providing pharmaceutical items, medicinal drugs, and formulations to its customers. For over five decades, Mercury Laboratories has been effectively delivering innovative products that meet global standards and adhere to health and safety regulations. As the company continues to experience success over the years, it has been able to pay dividends and rewards to its shareholders. With such values, they strive to provide effective pharmaceutical treatment throughout the world.

Revenue: ₹18.14Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.97Cr as on June 2025 (Q1 FY26)
Chairperson Name: Divyakant Ramniklal Zaveri
OrganisationMercury Laboratories Ltd
HeadquartersVadodara
IndustryPharmaceuticals
CEODivyakant Ramniklal Zaveri
E-voting on sharesClick here to vote

FAQs

What is Mercury Laboratories Ltd share price today?

Mercury Laboratories Ltd share price today stands at ₹864.2 as on . Mercury Laboratories Ltd share today touched a day high of ₹903.45 and a low of ₹863.55.

What is the 52 week high and 52 week low range for Mercury Laboratories Ltd share?

Mercury Laboratories Ltd touched a 52 week high of ₹1016 and a 52 week low of ₹736. Mercury Laboratories Ltd share price today i.e. is trending at ₹864.2, which is -14.94% down from its 52 week high and 17.42% up from its 52 week low.

What is Mercury Laboratories Ltd's market capitalisation today?

Mercury Laboratories Ltd market capitalisation is ₹103.70 Cr as on .

How to buy Mercury Laboratories Ltd shares?

To buy Mercury Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 538964 or Mercury Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mercury Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mercury Laboratories Ltd trading volume today?

Mercury Laboratories Ltd trading volume is 135.00 as on . This means that 135.00 shares of Mercury Laboratories Ltd were bought and sold on the stock market during today's trading session.